Pseudotyped adeno-associated viral vector tropism and transduction efficiencies in murine wound healing

Wound Repair and Regeneration

Volumn 20, Issue 4, 2012, Pages 592-600

  Keswani, Sundeep G ^a,b,e   Balaji, Swathi ^a   Le, Louis ^a   Leung, Alice ^a   Lim, Foong Yen ^a,b   Habli, Mounira ^a   Jones, Helen N ^a   Wilson, James M ^c   Crombleholme, Timothy M ^a,b,d  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^e CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR;

ADENO ASSOCIATED VIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; EPIDERMIS CELL; GENE TRANSFER; HUMAN; HUMAN CELL; KERATINOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN CELL; TROPISM; VIRAL GENE DELIVERY SYSTEM; VIRUS CAPSID; WOUND HEALING;

ANIMALS; DEPENDOVIRUS; DISEASE MODELS, ANIMAL; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; KERATINOCYTES; MICE; MICE, INBRED C57BL; PARVOVIRIDAE INFECTIONS; TRANSDUCTION, GENETIC; VIRAL TROPISM; WOUND HEALING; WOUND INFECTION;

EID: 84863474581     PISSN: 10671927     EISSN: 1524475X     Source Type: Journal    
DOI: 10.1111/j.1524-475X.2012.00810.x     Document Type: Article

References (29)

1. Jeffcoate WJ, Harding KG,. Diabetic foot ulcers. Lancet 2003; 361: 1545-1551. (Pubitemid 36566350)
2. Wieman TJ, Smiell JM, Su Y,. Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers. A phase III randomized placebo-controlled double-blind study. Diabetes Care 1998; 21: 822-827. (Pubitemid 28487079)
3. Liechty KW, Nesbit M, Herlyn M, Radu A, Adzick NS, Crombleholme TM,. Adenoviral-mediated overexpression of platelet-derived growth factor-B corrects ischemic impaired wound healing. J Invest Dermatol 1999; 113: 375-383. (Pubitemid 29449077)
4. Keswani SG, Katz AB, Lim FY, Zoltick P, Radu A, Alaee D, Herlyn M, Crombleholme TM,. Adenoviral mediated gene transfer of PDGF-B enhances wound healing in type I and type II diabetic wounds. Wound Rep Reg 2004; 12: 497-504. (Pubitemid 39314331)
5. Buchschacher GL Jr, Wong-Staal F,. Development of lentiviral vectors for gene therapy for human diseases. Blood 2000; 95: 2499-2504. (Pubitemid 30210526)
6. Lu Y,. Recombinant adeno-associated virus as delivery vector for gene therapy - a review. Stem Cells Dev 2004; 13: 133-145. (Pubitemid 38560050)
7. Allocca M, Mussolino C, Garcia-Hoyos M, Sanges D, Iodice C, Petrillo M, Vandenberghe LH, Wilson JM, Marigo V, Surace EM, Auricchio A,. Novel adeno-associated virus serotypes efficiently transduce murine photoreceptors. J Virol 2007; 81: 11372-11380. (Pubitemid 47536108)
8. Serrano F, Del Rio M, Larcher F, Garcia M, Munoz E, Escamez MJ, Muñoz M, Meana A, Bernad A, Jorcano JL,. A comparison of targeting performance of oncoretroviral versus lentiviral vectors on human keratinocytes. Hum Gene Ther 2003; 14: 1579-1585. (Pubitemid 37357744)
9. Donahue BA, McArthur JG, Spratt SK, Bohl D, Lagarde C, Sanchez L, Kaspar BA, Sloan BA, Lee YL, Danos O, Snyder RO,. Selective uptake and sustained expression of AAV vectors following subcutaneous delivery. J Gene Med 1999; 1: 31-42. (Pubitemid 129631061)
10. Connolly JB,. Lentiviruses in gene therapy clinical research. Gene Ther 2002; 9: 1730-1734.
11. Galeano M, Deodato B, Altavilla D, Cucinotta D, Arsic N, Marini H, Torre V, Giacca M, Squadrito F,. Adeno-associated viral vector-mediated human vascular endothelial growth factor gene transfer stimulates angiogenesis and wound healing in the genetically diabetic mouse. Diabetologia 2003; 46: 546-555. (Pubitemid 36577800)
12. Jazwa A, Kucharzewska P, Leja J, Zagorska A, Sierpniowska A, Stepniewski J, Kozakowska M, Taha H, Ochiya T, Derlacz R, Vahakangas E, Yla-Herttuala S, Jozkowicz A, Dulak J,. Combined vascular endothelial growth factor-A and fibroblast growth factor 4 gene transfer improves wound healing in diabetic mice. Genet Vaccines Ther 2010; 8: 6.
13. Hengge UR, Mirmohammadsadegh A,. Adeno-associated virus expresses transgenes in hair follicles and epidermis. Mol Ther 2000; 2: 188-194.
14. Gao GP, Alvira MR, Wang L, Calcedo R, Johnston J, Wilson JM,. Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy. Proc Natl Acad Sci U S A 2002; 99: 11854-11859. (Pubitemid 34994488)
15. Wang AY, Peng PD, Ehrhardt A, Storm TA, Kay MA,. Comparison of adenoviral and adeno-associated viral vectors for pancreatic gene delivery in vivo. Hum Gene Ther 2004; 15: 405-413. (Pubitemid 38469782)
16. Craig AT, Gavrilova O, Dwyer NK, Jou W, Pack S, Liu E, Pechhold K, Schmidt M, McAlister VJ, Chiorini JA, Blanchette-Mackie EJ, Harlan DM, Owens RA,. Transduction of rat pancreatic islets with pseudotyped adeno-associated virus vectors. Virol J 2009; 6: 61.
17. Kim I, Mogford JE, Chao JD, Mustoe TA,. Wound epithelialization deficits in the transforming growth factor-alpha knockout mouse. Wound Rep Reg 2001; 9: 386-390. (Pubitemid 34038767)
18. Perabo L, Endell J, King S, Lux K, Goldnau D, Hallek M, Büning H,. Combinatorial engineering of a gene therapy vector: directed evolution of adeno-associated virus. J Gene Med 2006; 8: 155-162. (Pubitemid 43250696)
19. Perabo L, Huber A, Marsch S, Hallek M, Buning H,. Artificial evolution with adeno-associated viral libraries. Comb Chem High Throughput Screen 2008; 11: 118-126. (Pubitemid 351347216)
20. Work LM, Buning H, Hunt E, Nicklin SA, Denby L, Britton N, Leike K, Odenthal M, Drebber U, Hallek M, Baker AH,. Vascular bed-targeted in vivo gene delivery using tropism-modified adeno-associated viruses. Mol Ther 2006; 13: 683-693.
21. Perabo L, Buning H, Kofler DM, Ried MU, Girod A, Wendtner CM, Enssle J, Hallek M,. In vitro selection of viral vectors with modified tropism: the adeno-associated virus display. Mol Ther 2003; 8: 151-157. (Pubitemid 36939306)
22. Girod A, Ried M, Wobus C, Lahm H, Leike K, Kleinschmidt J, Deléage G, Hallek M,. Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2. Nat Med 1999; 5: 1052-1056. (Pubitemid 29439578)
23. Chang DS, Su H, Tang GL, Brevetti LS, Sarkar R, Wang R, Kan YW, Messina LM,. Adeno-associated viral vector-mediated gene transfer of VEGF normalizes skeletal muscle oxygen tension and induces arteriogenesis in ischemic rat hindlimb. Mol Ther 2003; 7: 44-51. (Pubitemid 36312923)
24. Melo LG, Agrawal R, Zhang L, Rezvani M, Mangi AA, Ehsan A, Griese DP, Dell'Acqua G, Mann MJ, Oyama J, Yet SF, Layne MD, Perrella MA, Dzau VJ,. Gene therapy strategy for long-term myocardial protection using adeno-associated virus-mediated delivery of heme oxygenase gene. Circulation 2002; 105: 602-607. (Pubitemid 34123435)
25. Crombleholme TM,. Adenoviral-mediated gene transfer in wound healing. Wound Rep Reg 2000; 8: 460-472. (Pubitemid 32141450)
26. Hildinger M, Auricchio A, Gao G, Wang L, Chirmule N, Wilson JM,. Hybrid vectors based on adeno-associated virus serotypes 2 and 5 for muscle-directed gene transfer. J Virol 2001; 75: 6199-6203. (Pubitemid 32553151)
27. Tumbar T, Guasch G, Greco V, Blanpain C, Lowry WE, Rendl M, Fuchs E,. Defining the epithelial stem cell niche in skin. Science 2004; 303: 359-363. (Pubitemid 38095773)
28. Boutin S, Monteilhet V, Veron P, Leborgne C, Benveniste O, Montus MF, Masurier C,. Prevalence of serum IgG and neutralizing factors against adeno-associated virus (AAV) types 1, 2, 5, 6, 8, and 9 in the healthy population: implications for gene therapy using AAV vectors. Hum Gene Ther 2010; 21: 704-712.
29. Nakai H, Montini E, Fuess S, Storm TA, Grompe M, Kay MA,. AAV serotype 2 vectors preferentially integrate into active genes in mice. Nat Genetics 2003; 34: 297-302. (Pubitemid 36792862)